Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Chemotherapy. Catholic University, Campobasso, Campobasso, Italy

Survival: 12.9 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: Italy
City/State/Province: Campobasso
Hospital: Catholic University, Campobasso
Journal: Link
Date: 2/2008

Patients: This phase III trial involved 153 women with recurrent or progressive ovarian cancer. The median age was 63 years old, ranging from 28 to 80.

Treatment: The women were treated with either gemcitabine or pegylated liposomal doxorubicin. Both of these are chemotherapy drugs.

Toxicity: Grade 3/4 neutropenia was reported in 16 patients treated with gemcitabine and 5 patients treated with doxorubicin. Grade 3 or 4 anemia, thrombocytopenia, fatigue, nausea, diarrhea, mucositis, and allergic reaction occurred in up to 6% of patients.

Results: The median overall survival was 12.9 months (56 weeks) in patients treated with pegylated liposomal doxorubicin, and 11.7 months (51 weeks) in those treated with gemcitabine.

Correspondence: Dr. Gabriella Ferrandina

E-mail to a Friend Email Physician More Information